Author

admin

Browsing

The ARKK Innovation ETF (ARKK) stock price has rebounded over the past few weeks as trade jitters have eased. After falling to a low of $38.65 earlier this month, it has bounced back to $51, and is hovering at its highest level since March 26. This article explains whether Cathie Wood’s flagship fund is a good investment.

ARKK ETF is expensive for no reason

The ARKK Innovation ETF is the flagship one by Cathie Wood, a popular figure in the financial market. It has over $4.5 billion in assets, which is significantly lower than its peak of over $13 billion. It is an actively managed fund that charges customers a whopping 0.75%. In contrast, popular ETFs like the Vanguard S&P 500 (VOO) and iShares (S&P 500) charge investors just 0.03%. 

Therefore, an ARKK investor with $10,000 will pay Cathie Wood $75 and Vanguard and BlackRock just $3 for the same investment. At times, it makes sense to pay a premium for a unique exchange-traded fund (ETF) that offers unique features and performance. 

For example, an ETF like the JPMorgan Nasdaq Equity Premium Income (JEPQ) charges 0.35%, which is a reasonable fee because it pays investors a double-digit yield by using the covered call strategy. 

Also, it is also reasonable to pay a premium for an ETF that outperforms benchmark assets like the Nasdaq 100 and the S&P 500 indices. ARKK does not do that and has a long history of lagging these assets. 

For example, the fund’s price return in the last five years was minus 5.20%, while the Invesco QQQ (QQQ) and the SPDR S&P 500 (SPY) rose by 123% and 92%, respectively. Keep in mind that the other two funds have an expense ratio of 0.25% and 0.09%, respectively. 

ARKK ETF vs S&P 50 and Nasdaq 100

Why ARKK ETF stock is rising

The ARKK ETF stock has jumped recently as many technology companies rally. Tesla stock price has jumped by over 32% from its lowest level this year after Elon Musk said that he would refocus on the company. He made this statement last week, following the company’s publication of weak financial results. 

Still, analysts caution that Tesla faces more challenges than opportunities in the past. The most significant factor is that its business is facing real competition from Chinese brands such as XPeng, BYD, and Li Auto. These companies are becoming more innovative than Tesla, especially in the battery technology.

Palantir stock price has jumped by over 73% from the year-to-date low, and is nearing its all-time high of $125. The risk, as we have written before, is that Palantir seems to be highly overvalued, considering that the AI bubble seems to be bursting. 

Coinbase stock price has jumped by over 44% from the lowest swing this year. As we wrote recently, it has formed an inverse cup and handle pattern, pointing to an eventual retreat in the coming weeks.

The other top companies in the ARKK ETF, like Roku, Roblox, Tempus AI, CRISPR Therapeutics, Robinhood, and Archer Aviation, are all risky. 

Summary 

ARKK ETF had a nice run during the pandemic as it trounced popular funds like those tracking the S&P 500 and the Nasdaq 100 indices. Since then, however, the gains have been weaker, confirming the view that active funds underperform their passive counterparts.

While Cathie Wood’s ETF will occasionally outperform the benchmarks, the long-term trend is that it will generally lag behind them. As such, most experts recommend allocating their funds in these traditional funds since they are cheaper and have a long track record of performance.

The post Cathie Wood’s ARKK ETF is rising: is it a good tech fund to buy? appeared first on Invezz

XRP price has done well since its founding in 2013. It has jumped by almost 40,000% since then, while its market cap has soared to over $130 billion. This makes it bigger than some well-known companies like Micron, Brookfield Asset Management, Lam Research, Intel, and UPS. This article provides a Ripple prediction and highlights what to expect by 2030.

Ripple price to depend on Bitcoin’s performance 

The XRP price forecast for 2030 will depend on the state of cryptocurrencies at that time and how Ripple Labs executes its plans. 

History shows that cryptocurrencies, especially Bitcoin, rise over time. This rebound is never linear, and it normally has a few bumps along the way. For example, after soaring to a record high of $109,300 earlier this year, Bitcoin then fell to $74,000 in early January.

Analysts are highly bullish on the Bitcoin price. Standard Chartered expects that the coin will jump to $200,000 by the end of the year. Ark Invest predicts it will rise to $2.4 million by 2030, a move that would bring its diluted market capitalization to over $50 trillion. 

Michael Saylor, on the other hand, sees Bitcoin rising to over $45 million in the long term. This explains why his company has continued to accumulate Bitcoins in the past few years.

If these forecasts are correct, then it makes sense to assume that XRP price will be much higher by 2030. 

Ripple Labs impact on payments

The other key catalyst that will impact the XRP price action by 2030 will be how Ripple Lab performs in the payments industry.

Ripple Labs aims to become the world’s largest payment network. Precisely, it aims to provide banks and other sector players with a viable alternative to SWIFT, a network that facilitates the movement of trillions of dollars annually. 

Ripple’s path to global domination was hindered by the Securities and Exchange Commission (SEC) lawsuit, which accused it of selling unregistered securities. The immediate impact of that lawsuit was that some of its then partners dropped off. It also became difficult for the company to do attract major US partnerships.

Now, with the case done, Ripple hopes to enlist most American companies to its network. Its pitch is that its payment system is faster and cost-friendly. And for banks concerned about using XRP, the RippleNet network does not require the use of the coin. 

Furthermore, Ripple’s stablecoin (XRP) will likely have a larger market share in the industry by that time. The stablecoin now has a market cap of almost $300 million a few months after launch. By 2030, this valuation will be over $10 billion if the trend continues. 

XRP price technical analysis 

XRP price chart | Source: TradingView

The chart above shows that the XRP price went parabolic in November last year. It surged and retested the important resistance level at $3.30. This was a key level because it coincided with the previous all-time high. 

Measuring the distance between that level and its lowest point in 2020 can help us predict the long-term target for the coin. This measurement shows that the depth is about 97%. Measuring the same distance from the all-time high gives the target at $6.50, up by over 185% from the current level.

The post XRP price prediction: how high can Ripple get by 2030? appeared first on Invezz

Shares of Hims & Hers Health soared more than 34% in premarket trading on Tuesday after Novo Nordisk announced a partnership with the telehealth company to expand access to its popular weight loss drug Wegovy.

Novo’s stock also rose 3% as the Danish drugmaker revealed it will now work with Hims & Hers, Ro, and LifeMD to distribute Wegovy directly to patients in the United States.

The new strategy comes amid a broader push by Novo Nordisk to regain control of the weight loss drug market as compounding pharmacies—a cheaper and more accessible workaround during periods of short supply—face growing regulatory scrutiny and restrictions.

It also follows rival Eli Lilly & Co.’s partnership with Ro to offer its obesity drug Zepbound at a lower price, starting at $349 per month.

In contrast, Lilly has no formal partnership with Hims & Hers, which offers Zepbound independently on its platform for $1,899 per month, including a membership fee.

Hims & Hers (HIMS) bolsters offering amid rising competition

Hims & Hers said it will begin offering all dosage sizes of Wegovy this week, including access to continuous clinical support, with pricing starting at $599 per month.

CEO Andrew Dudum said the partnership would provide an example of how patients can gain convenient, quality access to breakthrough treatments.

The company had earlier sold compounded versions of semaglutide but began scaling back those offerings as regulatory clarity emerged and supplies of the branded drug normalized.

“That was one of the first things we shared with Novo is that we will always fight on behalf of what consumers we believe have the right to get,” Dudum said. “The regulation is very clear.” 

While Hims & Hers is now formally partnered with Novo Nordisk, its relationship with Eli Lilly, which makes the competing drug Zepbound, is less official.

Hims & Hers began offering Zepbound and Lilly’s diabetes drug Mounjaro on its platform earlier this month.

However, Lilly later clarified that it has “no affiliation” with the company, even though Zepbound is also being distributed through telehealth rival Ro at a significantly lower price point of $349 per month.

Shift from compounded drugs to branded access

Novo Nordisk’s move reflects a change in market conditions.

A year ago, demand for GLP-1 drugs like Wegovy far outstripped supply, prompting many patients to turn to compounded versions made by smaller pharmacies.

These compounded semaglutide products filled the gap but faced criticism from drugmakers and regulators, as they are not FDA-approved and may vary in safety or efficacy.

Now that Wegovy is no longer in short supply in the US, Novo Nordisk is working to shift patients back to the branded product by leveraging the reach and convenience of telehealth services.

“We felt it was really important to work hard to establish a collaboration with telehealth companies so that there could be access to Wegovy as the compounding is winding down,” Dave Moore, executive vice president of US operations at Novo Nordisk, told CNBC.

Through this model, patients will be able to access the drug via NovoCare—Novo Nordisk’s direct-to-consumer online pharmacy—integrated into the telehealth platforms.

The price through NovoCare will be $499 per month for cash-paying customers, while prices through telehealth firms may be higher due to additional services like 24/7 care and nutritional counseling.

Analysts expect a fierce battle for market share

GLP-1 drugs like Wegovy, Ozempic, and Zepbound have become one of the most sought-after categories in modern medicine, initially for diabetes but now increasingly for weight loss.

Analysts widely expect them to become some of the highest-grossing drug classes globally.

With compounding on the decline and branded supply improving, the competition between Novo Nordisk and Eli Lilly is likely to intensify, especially as both companies lean on telehealth platforms to reach patients directly.

However, medical experts have urged caution, warning that easy access through online pharmacies must be balanced with safeguards to ensure proper usage and oversight.

Novo Nordisk’s latest telehealth push is designed to make that access easier but more controlled.

As Moore put it, the goal is to “catch people as they come off compounded medicine” and bring them into a more regulated environment.

For now, investors appear to back the strategy.

As Hims & Hers scales up branded offerings and integrates deeper with pharmaceutical partners, its role as a gateway for blockbuster drugs may only grow.

The post Hims & Hers Health (HIMS) stock surges 34% on partnership with Novo Nordisk to sell Wegovy appeared first on Invezz

US stocks opened mixed on Tuesday, with the S&P 500 and Nasdaq slipping as investors grew uneasy over the lack of progress on global trade negotiations.

The S&P 500 fell 0.3%, while the Nasdaq Composite lost 0.5%. The Dow Jones Industrial Average, however, managed a modest gain, adding 96 points or 0.2%.

Markets turned lower after US Treasury Secretary Scott Bessent, speaking at the White House, failed to provide meaningful updates on key trade talks.

While Bessent said substantial discussions were ongoing with Japan and a framework for a deal with India appeared close, he offered no specifics on negotiations with China, nor did he confirm whether talks were even taking place.

The ambiguity added to investor anxiety over escalating tariff risks.

Stocks in the news

Amazon shares dropped more than 1% after White House press secretary Karoline Leavitt called a reported plan by the e-commerce company to itemize tariff-related costs on its site a “hostile and political act.”

The comments, delivered alongside Bessent, appeared to deepen tensions between the administration and major corporate players.

General Motors also fell by over 2%. While the automaker beat profit expectations for the quarter, it suspended additional share buybacks and said it was reassessing its full-year guidance due to continued tariff uncertainty.

Coca-Cola shares traded flat in early trade after the company reported better-than-expected first-quarter earnings and revenue.

The beverage giant also reaffirmed its full-year guidance, providing a degree of reassurance to investors amid heightened global trade uncertainty.

In a statement, Coca-Cola said it expects any fallout from President Donald Trump’s tariff measures to be “manageable,” indicating confidence in its global supply chain and pricing strategies.

Markets are looking at earnings next

Investors are now looking ahead to earnings reports from major tech firms and further developments on trade, as market sentiment remains fragile.

Today’s volatile start comes after US stocks ended mixed on Monday, with the S&P 500 managing to log a fifth consecutive day of gains by a razor-thin margin.

The index added just 0.06%, while the Dow Jones Industrial Average rose 114.09 points, or 0.28%. The Nasdaq Composite slipped 0.1%, weighed down by weakness in tech names.

All three major benchmarks swung sharply during the session.

The Dow traded in a 540-point range, falling as much as 240 points before rebounding to gain nearly 300 points at its high.

General Motors, UPS, Coca-Cola, PayPal, JetBlue, and Pfizer all released their results before the opening bell, with Starbucks and Snap set to report after the market closes.

The earnings deluge comes at a critical juncture, with markets on edge over corporate outlooks and macroeconomic signals.

The post US stock open in the red: S&P down 0.3%, Nasdaq slips 0.5% appeared first on Invezz

NEWYou can now listen to Fox News articles!

It has been 100 days since the new U.S. administration took office amid a clear policy of ‘America First.’ 

But for American families like mine, families whose loved ones are still held hostage by Hamas for over 560 days, we should have already seen results from this policy. My son, Itay Chen, a dual U.S.-Israeli citizen, remains in captivity. So do four other Americans: Edan Alexander, Omer Neutra, Judy and Gadi Weinstein. Every day that passes without their return is another day of anguish, uncertainty, and pain.

As a father, I wake up every morning hoping this will be the day I get the call from the White House telling me my son is coming home. When President Donald Trump won the election, I felt a renewed sense of hope. I believed that his leadership, strength, and personal concern for American hostages would lead to real movement. And I deeply thank President Trump for demanding the release of all hostages even before his inauguration that led to the release of 33 hostages in Gaza, including two U.S. citizens. 

I believe he cares profoundly, but the truth is, the first 100 days of this administration have not delivered what the president himself demanded – releasing all of the U.S. hostages in Gaza and sending a clear message that holding U.S. hostages anywhere is a liability, not an asset. 

This is not a critique made in anger. It is a plea made in desperation. I understand that diplomacy is complex. I know that the negotiations around hostages—especially in a war zone and involving multiple international actors— require discretion, patience, and nuance. But I also know that time is not on our side. As the weeks pass, the fear grows that the window to bring our loved ones back is narrowing and they will disappear forever.

We have seen this administration act boldly in other arenas to implement the America First policy, particularly when it comes to economic policy. Tariffs and financial pressure have already been deployed as tools of American strength. 

Why not apply similar pressure now to release the U.S. hostages? Instead of the administration being proactive, U.S. families like mine, out of despair, are taking matters into our own hands. We’ve been lobbying Congress to impose direct financial sanctions against Hamas, pressuring banks and financial institutions to freeze assets and urging stricter enforcement of existing measures. Just this month, U.S. families filed a lawsuit against Bashar Masri, an American businessman charging that he provided assistance in constructing infrastructure that allowed Hamas militants to carry out their cross-border rampage, including killing 45 U.S. citizens. We’ve urged the Administration, the Department of Justice and the Treasury to expand these efforts. 

The administration can, and must, do more. Americans – children, fathers, sisters – are all still being held in underground tunnels by a terrorist organization, in conditions we can barely imagine. The previous administration told the American families the way to release our family members would be via Israel as a proxy. Though the plan did not work, the Biden administration kept doubling down on the same plan despite not getting the expected results. 

The Trump administration inherited this policy and should re-evaluate the game plan. President Trump is an extremely gifted negotiator. His team successfully released several U.S. citizens from war zones with direct negotiations. As such, why is President Trump not directly negotiating for the release of U.S. citizens in Gaza, but instead using third parties such as Qatar to negotiate for the release of U.S. citizens? In January, we saw what the president’s direct involvement can do to release hostages. The U.S. has a legal obligation to get its citizens out of harm’s way and if the proxy is not capable of releasing them, then the U.S. must find a different path to release its citizens.  

Trump administration officials have sent a clear message to the world that American lives are not bargaining chips. This administration has the opportunity to reinforce that principle—to lead with strength and show that ‘America First’ means never leaving Americans behind.

I will not lose hope. My faith in America’s power and promise is unbroken. But that hope needs to be matched with action. For Itay. For the other hostages. For the credibility – and the soul – of a nation that is seeking to reset the table with the world based on a true ‘America First’ policy. What a victory it would be if President Trump, in his upcoming visit to the Middle East, will bring on his plane back home the 5 U.S. hostages from Gaza.

This post appeared first on FOX NEWS

Rep. Marie Gluesenkamp Perez, D-Wash., described Rep. Nancy Pelosi, D-Calif., during her 2022 campaign as unrepresentative of American voters, but campaign finance reports revealed she collected at least $31,000 from the former House speaker and her political action committees during her three years in Congress. 

‘I want to make my position clear that I will not vote for Nancy Pelosi as Speaker of the House,’ Perez told The Columbian in 2022. ‘I look around, I look at my community, and I don’t see leadership in Congress looking like that.’

Despite the moderate Democrat rejecting Pelosi’s leadership on the campaign trail, campaign finance reports show that since she took office in 2022, Gluesenkamp Perez and her Super PAC, Marie Gluesenkamp Perez Campaign Defense Fund, have accepted at least $31,000 from Pelosi and her affiliated Super PACs, including PAC to the Future and Nancy Pelosi for Congress.

According to U.S. Census data, the $31,000 represents more than one third of the median household income for residents in Washington’s third congressional district, which includes Clark County and Vancouver, Washington, the district’s largest city.

‘We need more and more normal people to run for Congress. We need more people that work in the trades,’ Gluesenkamp Perez told Politico in 2023, as she described a Democratic Party out of touch with middle-class Americans. 

‘Just like her pal Nancy Pelosi, Marie Gluesenkamp Perez will say and do anything to get elected,’ Congressional Leadership Fund, the super PAC dedicated to maintaining the Republican majority in the U.S. House of Representatives, spokeswoman Torunn Sinclair, told Fox News Digital. 

‘That’s not a quality Washington State families want in their congresswoman.’

Gluesenkamp Perez was first elected to represent Washington in the U.S. House of Representatives in 2022 and won re-election in 2024, narrowly defeating her Republican challenger, Joe Kent, for the second time in two House cycles. 

The Washington congresswoman is considered one of the most vulnerable House Democrats in 2026, just as she was in 2024 after winning her 2022 race by less than two points. Republicans are likely to target her seat as an opportunity to widen their majority in the House. 

While Republicans slam Gluesenkamp Perez for flip-flopping on Pelosi, she is also facing the fury of her own party as hundreds of Democratic constituents protested at her town hall on Thursday. 

According to local reporting, including KGW News, protesters held up signs that read, ‘Shame on you,’ and chanted, ‘Vote her out,’ as Gluesenkamp Perez explained why she voted in support of the Safeguarding American Voter Eligibility (SAVE) Act. 

The SAVE Act, which passed in the House earlier this month, requires voters to obtain proof of citizenship in-person before they register for a federal election and will remove noncitizens from voter rolls. It has been widely rejected by Democrats since its conception, and 208 House Democrats voted against the bill. 

‘I do not support noncitizens voting in American elections – and that’s common sense to folks in Southwest Washington. Voting in our nation’s elections is a sacred right belonging only to American citizens, and my vote for the SAVE Act reflects that principle,’ Gluesenkamp Perez said after voting in support of the SAVE ACT, despite facing vocal opposition from constituents on Thursday for doing so. 

Gluesenkamp Perez also faced disapproval from Washington state Democrats for voting to censure Rep. Al Green, D-Texas, after he shouted and shook his cane during President Donald Trump’s joint address to Congress earlier this year.  

Gluesenkamp Perez’s campaign did not respond to Fox News Digital’s request for comment by deadline. 

This post appeared first on FOX NEWS

President Donald Trump’s second term has taken the world by storm in his first 100 days, leaving allies and adversaries scrambling to respond to new U.S. tariffs, stalled peace negotiations and hardball diplomacy from the White House.

On the campaign trail, he pledged to hit allies and foes alike with massive tariffs, end Russia’s war in Ukraine within 24-hours and threatened that ‘all hell’ would break out if all hostages were not freed from the clutches of Hamas in Gaza by the time he entered the Oval Office.

While Trump has been able to make good on some of his promises, other ambitions remain unmet. Here’s what Trump has accomplished and what challenges remain:

Where Russia’s war in Ukraine stands

Trump last week conceded that his pledge to end the three-year-old war in Ukraine within 24 hours of taking office was ‘figurative,’ acknowledging it was never a realistic goal. The conflict has claimed a reported 1 million casualties.

‘I said that as an exaggeration,’ he told reporters. 

While Trump has faced criticism over his ability to bring Russian President Vladimir Putin to the negotiating table, his team — led by Special Envoy Steve Witkoff and Secretary of State Antony Rubio — has made some headway, securing a 30-day ceasefire protecting Ukraine’s energy infrastructure.

But Putin has so far refused to enter any other brokered agreements, despite Kyiv’s willingness to play ball even after the historic Oval Office blow-up between Trump and Ukrainian President Volodymyr Zelenskyy in February.

Though Trump appeared to hold a grudge against Zelenskyy after Ukraine rejected a proposed mineral deal — even blaming him in part for Russia’s illegal invasion — relations between the two leaders appeared to improve over the weekend. Trump also set a new ultimatum for Putin, issuing a deadline to reach a ceasefire deal.

‘Two weeks or less,’ Trump told reporters Sunday, though he later added a bit more time would be acceptable. ‘We’ll see what happens over the next few days. We’ll probably learn a lot.’

Trump said he was ‘surprised and disappointed’ after Putin last week levied a barrage of missiles at Ukraine’s capital city of Kyiv in a strike that killed 12 civilians and injured nearly 100 more.

‘I want him to stop shooting, sit down and sign a deal,’ Trump said in reference to Putin. ‘We have the confines of a deal, I believe, and I want him to sign it and be done with it and just go back to life.’

Trump has not said how or whether he will hold Putin accountable if he doesn’t agree to a ceasefire and the White House has not responded to Fox News Digital’s repeated questions regarding the issue.

Gaza ceasefire

Before entering office, Trump repeatedly threatened Hamas that ‘all hell’ would break out if they didn’t return all hostages by the time he arrived at the White House. 

But the Palestinian terror group has ignored his threats and rejected Trump’s February proposal to turn the Gaza Strip into the ‘Riviera of the Middle East,’ saying it would adhere to a ceasefire agreement brokered between the terrorist organization and Israel, mediated by the U.S., Qatar and Egypt. 

Trump has not hit Hamas, nor have his negotiations to release hostages looked all that different from his predecessor’s.  

The first phase of what was intended to be a three-phase ceasefire saw the return of 33 hostages taken by Hamas, the majority of whom were abducted in the Oct. 7, 2023 attack on Israel, as well as the release of 1,800 Palestinian prisoners held by Jerusalem. 

But 59 hostages remain in Gaza, including American-Israeli Edan Alexander, and hopes of a second phase collapsed after negotiations stalled on terms surrounding future hostage releases, and in March Israel reignited military operations in the Gaza Strip.

A Qatari official on Sunday said the main hiccup in securing a ceasefire following the latest round of talks last week is that Israel has not presented a clear solution to end the war in exchange for hostage releases, Reuters reported. 

Trump on Friday said he pushed Israeli Prime Minister Netanyahu to reopen aid corridors into Gaza, which have been blocked since March 2, in order to allow food and medicine to reach Palestinians, though humanitarian corridors have not yet been opened. 

Iran nuclear agreement

Trump on Sunday said he believes a deal to end Iran’s nuclear program can be achieved ‘without having to start dropping bombs all over the place.’

Details on nuclear negotiations between the U.S. and Iran in Oman on Saturday, in which the third round of talks were held, remain nil, though Iranian Foreign Minister Abbas Araghchi reportedly told Iranian state media they were ‘very serious and work-focused.’ 

Araghchi described the hours-long talks as having finally ‘entered into deeper and more detailed discussions,’ though no specifics of the negotiations have been released. 

It remains unclear if the Trump administration is pursuing a halt to Tehran’s nuclear advancement or a complete disarmament arrangement, which would see the destruction of Iran’s centrifuge facilities and its stockpiles of near-weapons-grade enriched uranium. 

It also remains unclear how much time the president will allow for the negotiations to carry on. 

Relations with China deteriorate

Relations between the U.S. and China have hit a level of animosity not seen between the two superpowers since Washington normalized ties with the Chinese Communist Party (CCP) in the 1970s. 

The initial U.S.-China trade war started during Trump’s first term, in which he hit China with 25% tariffs on $50 billion in Chinese goods in April 2018.

Beijing responded by slapping reciprocal tariffs on $50 billion worth of U.S. goods, mostly targeting U.S. agricultural products worth some $16.5 billion — a trade war that saw the loss of a quarter of a million U.S. jobs by January 2021, according to the U.S.-China Business Council (USCBC).

From the campaign trail, Trump threatened to hit China with 60% tariffs — which he nearly did in early April when he announced an additional 34% tariff on top of the existing taxes already in place. 

But what had already sent geopolitical shockwaves and sparked near-immediate market concerns was further escalated just over a week later when Trump ratcheted up tariffs on Beijing to 145%. 

China has responded by hitting Washington with its own 125% reciprocal tariffs on U.S. imports and, according to a Bloomberg report on Monday, cargo supply shipments have already dropped by 60%.

Americans are expected to begin feeling the pains of the trade war come mid-May.

Trump said last week he had reached some 200 trade deals with countries affected by his sweeping tariffs — measures that hit nearly every U.S. trading partner, including longtime allies. He paused the tariffs for 90 days earlier this month following intense backlash.

The status of trading relations with U.S. partners remains unclear, along with whether the administration will implement the blanket tariffs on those nations come July.

The 25% tariffs on steel, aluminum and imported vehicles remain in effect.

The White House did not directly respond to Fox News Digital’s questions regarding next steps Trump will takes when it comes to handling thus far unresolved conflict in Ukraine and the Gaza Strip.

A White House spokesman instead said, ‘President Trump inherited widespread foreign conflicts and a weak standing on the world stage from Joe Biden. Now, America is strong again, hostages are free from Gaza, Marc Fogel and Ksenia Karelina are home, hundreds of Houthi and other terrorists have been eliminated, and we are closer to peace than ever before. 

‘This President will never get the credit he deserves for his vast foreign policy accomplishments, but Americans know they are freer and safer under his leadership,’ the spokesman added.

This post appeared first on FOX NEWS